Skip to content

Optimising team functioning, preventing relapse and enhancing recovery in Crisis Resolution Teams (CRTs): the CORE Programme (Crisis team Optimisation and RElapse prevention) CORE Phase 4: A Cluster Randomised Controlled Trial: Evaluation of implementation of a CRT Resource Kit

Optimising team functioning, preventing relapse and enhancing recovery in Crisis Resolution Teams (CRTs): the CORE Programme (Crisis team Optimisation and RElapse prevention) CORE Phase 4: A Cluster Randomised Controlled Trial: Evaluation of implementation of a CRT Resource Kit

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47185233
Enrollment
1265
Registered
2014-08-14
Start date
2014-07-16
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Mental Health

Interventions

This is a multi-site, cluster-randomised controlled trial (with CRT service as the unit of randomisation) comparing outcomes for 15 CRTs that receive a CRT resource kit over a one-year study period, w

Sponsors

Camden and Islington NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Service user inclusion criteria: Adults (aged 18+) who have been on the caseload of a participating Crisis Resolution Team for at least a week CRT inclusion criteria: UK CRT Target Gender: Male & Female; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: Service user exclusion criteria: 1. People who lack capacity to consent to take part in the study 2. People who in the view of the clinical team at their Crisis Resolution Team present such a high risk of harm to others, it would be unsafe for researchers to contact them about participation, even just by phone or email. 3. People who are discharged to addresses outside the catchment area. 4. People who cannot understand the study information sheet or questionnaire when delivered in English. CRT exclusion criteria: 1. CRT teams identified in a previous national survey conducted at an earlier stage of the CORE study as already operating at high fidelity (mean item score above 4) - i.e. teams with comparatively little capacity for service improvement 2. CRT teams where major change to the organisation of the service is planned during the duration of the trial 3. CRTs taking part in the concurrent CORE Phase 3 trial

Design outcomes

Primary

MeasureTime frame
Service user satisfaction with CRT care measured by Client Satisfaction Questionnaire; Timepoint(s): Approx. 12 months after commencement of intervention compared to baseline

Secondary

MeasureTime frame
1. Patient Records Admission Data (admission rates, bed use and readmissions to acute care); Timepoint(s): Admissions and readmissions over 6 months 2. Service user experienced continuity of care measured using Continu-um; Timepoint(s): Approx. 12 months after commencement of intervention compared to baseline 3. The General Health Questionnaire- Staff; Timepoint(s): Baseline and 12 months 4. Maslach Burnout Inventory - Staff; Timepoint(s): Baseline and 12 months 5. The Work Engagement Scale - Staff; Timepoint(s): Baseline and 12 months 6. The Work-Related Acceptance and Action Questionnaire - Staff; Timepoint(s): Baseline and 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 13, 2026